US NIH National Institute of Allergy and Infectious Diseases: Molecular and Genetic Characterisation of Inborn Errors of Immunity (R01 and R21 Clinical Trials Not Allowed)

Please note: Due date varies according to Award Mechanism. See Submission Requirements and Due Dates section for details.

About the Program

The National Institute of Allergy and Infectious Disease invites applications for its Molecular and genetic characterisation of inborn errors of immunity program. The following award mechanisms support research that aims to advance the experimental validation and functional characterisation of genetic variants in coding or non-coding genomic regions, that result in inborn errors of immunity or primary immunodeficiency diseases, and to elucidate the molecular, cellular, and immunological mechanisms of these disorders.

R01 Research Project Grants (Clinical Trials not Allowed)

  • Funding: Application budgets are not limited but need to reflect the actual needs of the proposed project.
  • Duration: The maximum project period is five years.
  • Visit the website for this scheme
  • About R01 Research Project Grants

R21 Exploratory/Developmental Research Grants (Clinical Trials not Allowed)


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements & Due Date

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences and tagged . Bookmark the permalink.

Comments are closed.